Seeing Is Believing
REVB is currently covered by 1 analysts with an average price target of $4.68. This is a potential upside of $2.3 (96.64%) from yesterday's end of day stock price of $2.38.
Revelation Biosciences's activity chart (see below) currently has 0 price targets and 3 ratings on display. The stock rating distribution of REVB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 100% with an average time for these price targets to be met of 244 days.
Highest price target for REVB is $81, Lowest price target is $81, average price target is $4.68.
Most recent stock forecast was given by JONATHAN ASCHOFF from ROTH on 14-Feb-2023. First documented stock forecast 17-Feb-2022.
Currently out of the existing stock ratings of REVB, 1 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$1.36 (37.36%)
12
1 years 2 months 24 days ago
3/3 (100%)
$2.3 (85.19%)
244
What is REVB (Revelation Biosciences) average time for price targets to be met?
Which analyst has the current highest performing score on REVB (Revelation Biosciences) with a proven track record?
Which analyst has the most public recommendations on REVB (Revelation Biosciences)?
Which analyst is the currently most bullish on REVB (Revelation Biosciences)?